← FDA Drug Approvals (Drugs@FDA)

MIDAZOLAM IN 0.8% SODIUM CHLORIDE

NDA · New Drug Application · Sponsor: EXELA PHARMA · Approved 2022-07-20

Drug application

FDA Application #

NDA215868

Application type

New Drug Application

Brand name

MIDAZOLAM IN 0.8% SODIUM CHLORIDE

Generic name

Midazolam

Active ingredients

MIDAZOLAM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

EXELA PHARMA

First approval

2022-07-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown